Artios signs research collaboration with MU to develop novel cancer treatments

12 Jun 2017

Cambridge, UK, 12 June 2017. Artios Pharma Ltd., a leading DNA Damage Response (DDR) company developing innovative new treatments for cancer, today announces it has signed a research collaboration and option agreement with Masaryk University MU in the Czech Republic for the development of novel cancer treatments targeting DNA nucleases involved in the DDR.

Read the whole press release here.

26 Sep

CTT MU Participated in Prague.bio Conference 2025

On Thursday, September 25, the third edition of the Prague.bio Conference 2025 took place in Prague, bringing together over 400 participants from around the world.
11 Sep

The second call for new Proof of Concept (PoC) projects is now open

Masaryk University accepts PoC projects focused on supporting the application potential of science and research.
1 Sep

Register for the first round of Life Science Transfer Academy - From Discovery to Innovation!

Gain practical skills to transform your research in biotechnology, pharmacy, and medicine into innovations ready for the market – with a focus on intellectual property protection, commercialization, industry collaboration, and spin-off creation. The program starts on October 1. Apply by September 10!
21 May

Aplikace pro podporu onkologicky nemocných pacientů: soutěž Start Your Business 2025 zná svého vítěze

All articles

Artios signs research collaboration with MU to develop novel cancer treatments

More articles

CTT MU Participated in Prague.bio Conference 2025

The second call for new Proof of Concept (PoC) projects is now open

Register for the first round of Life Science Transfer Academy - From Discovery to Innovation!

Aplikace pro podporu onkologicky nemocných pacientů: soutěž Start Your Business 2025 zná svého vítěze